U.S., Nov. 19 -- An application to own the trademark for 'ABZORVE' has been filed on May. 27, 2025.
Owner(s):
Glaxo Group Limited; GSK Medicines Research Centre, Gunnels Wood Road, UNITED KINGDOM
Goods and/or Services:
For: Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for t...